Currently submitted to: JMIR Cardio
Date Submitted: May 22, 2026
Open Peer Review Period: May 25, 2026 - Jul 20, 2026
(currently open for review)
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
MyHEART-DM Score: A Predictive Screening Risk Scoring Tool for Ischemic Heart Disease Among Malaysian Patients with Type 2 Diabetes Mellitus
ABSTRACT
Background:
Ischemic heart disease (IHD) remains the leading cause of mortality worldwide, with patients with type 2 diabetes mellitus (T2DM) experiencing substantially increased cardiovascular risk.
Objective:
This study aimed to develop and validate the MyHEART-DM Score, a prognostic screening tool for predicting IHD risk among Malaysian patients with T2DM using real-world registry data.
Methods:
A retrospective cohort study was conducted using data from the National Diabetes Registry (NDR) Johor, Malaysia, from 2020 to 2024. Patients were divided into development (2020–2021), internal validation (2022–2023), and external validation (2024) cohorts. Multivariable logistic regression was used to develop the prognostic model, and weighted scores were generated using a shrinkage approach. Model performance was assessed using discrimination and calibration analyses.
Results:
A total of 11,082, 13,068, and 7,613 patients were included in the development, internal validation, and external validation cohorts, respectively. The final MyHEART-DM Score incorporated 15 prognostic variables and demonstrated moderate but consistent discrimination across all cohorts, with area under the receiver operating characteristic curve values of 0.686, 0.694, and 0.687, respectively. Calibration performance was satisfactory, with calibration intercepts close to 0 and slopes close to 1 across all cohorts. The score stratified patients into low (<20), intermediate (20–40), and high-risk (>40) categories, with progressively higher odds of IHD observed across risk groups.
Conclusions:
The MyHEART-DM Score may serve as a practical tool for IHD risk stratification among Malaysian patients with T2DM in primary care settings and may contribute toward achieving Sustainable Development Goal 3 by supporting early detection and prevention of cardiovascular complications among high-risk populations. Further prospective validation and integration into clinical decision support systems are recommended. Clinical Trial: Not applicable.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.